VitaNova Life Sciences (VNOV) EPS (Basic) (QoQ) (2018 - 2026)
VitaNova Life Sciences (VNOV) EPS (Basic) (QoQ) (2018 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Mckesson | 102.06 Bn | 96.90 Bn | 3.69 Bn |
| 2 | Cencora | 61.56 Bn | 58.74 Bn | 3.61 Bn |
| 3 | Cardinal Health | 54.39 Bn | 49.53 Bn | 2.56 Bn |
| 4 | Henry Schein | 10.03 Bn | 9.87 Bn | 1.10 Bn |
| 5 | Akso Health | 820.26 Mn | 820.04 Mn | - |
| 6 | Edap Tms | 157.43 Mn | 135.89 Mn | 7.34 Mn |
| 7 | Accendra Health | 97.79 Mn | 90.14 Mn | 263.41 Mn |
| 8 | 111 | 30.87 Mn | 109.39 Mn | 18.18 Mn |
| 9 | Cosmos Health | 13.16 Mn | 10.71 Mn | 1.51 Mn |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 139.56% |
| Jan 31, 2026 | -471.64% |
| Oct 31, 2025 | 177.34% |
| Jul 31, 2025 | -105.79% |
| Apr 30, 2025 | 996.68% |
| Jan 31, 2025 | 123.54% |
| Oct 31, 2024 | 159.13% |
| Jul 31, 2024 | -113.99% |
| Apr 30, 2024 | 1,512.51% |
| Jan 31, 2024 | 165.61% |
| Oct 31, 2023 | 63.89% |
| Jul 31, 2023 | -452.95% |
| Apr 30, 2023 | 82.16% |
| Jan 31, 2023 | -1,044.91% |
| Oct 31, 2022 | 21.88% |
| Jul 31, 2022 | 107.96% |
| Apr 30, 2022 | -400.63% |
| Jan 31, 2022 | -40.59% |
| Oct 31, 2021 | -89.47% |
| Jul 31, 2021 | 805.97% |